This trial tests if a program aiming to improve retention in MAT, reduce substance-related harm and increase cultural connectedness is effective.
- Opioid Use Disorder
1 Primary · 5 Secondary · Reporting Duration: Baseline, month 1, month 3, month 6
2 Treatment Groups
Treatment as Usual (TAU)
1 of 2
1 of 2
160 Total Participants · 2 Treatment Groups
Primary Treatment: CHaRRM-CN · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are individuals still able to join this clinical experiment?
"Affirmative. Clinicaltrials.gov records demonstrate that this research project, which was first published on January 17th 2023, is currently enrolling volunteers. Approximately 160 individuals are sought to participate in the trial at a single location." - Anonymous Online Contributor
What is the current enrollment of participants in this clinical investigation?
"Affirmative. According to clinicaltrials.gov, the recruitment phase of this medical experiment began on January 17th 2023 and concluded February 15th 2023. 160 patients are required between 1 facility for its completion." - Anonymous Online Contributor